2026-06911NoticeWallet

FDA Bids Farewell to Old-School Cancer Drug Tablets

Published Date: 4/10/2026

Notice

Summary

GlaxoSmithKline has stopped selling Wellcovorin tablets and asked the FDA to withdraw its approval for these drugs as of April 10, 2026. This means Wellcovorin tablets (5 mg and 25 mg) can no longer be legally sold or shipped, but pharmacies can use up any leftover stock until it runs out or expires. If needed, GSK can apply again in the future to bring the drug back.

Analyzed Economic Effects

3 provisions identified: 1 benefits, 1 costs, 1 mixed.

Wellcovorin approval withdrawn

The FDA withdrew approval of GlaxoSmithKline's New Drug Application (NDA 018342) for Wellcovorin (leucovorin calcium) tablets, EQ 5 mg and EQ 25 mg, effective April 10, 2026. After that date, introducing or delivering these products into interstate commerce without an approved NDA violates the Federal Food, Drug, and Cosmetic Act.

Existing stock may still be dispensed

Any Wellcovorin (leucovorin calcium) tablets, EQ 5 mg and EQ 25 mg, that were in inventory on April 10, 2026 may continue to be dispensed until inventories are depleted, the products reach their expiration dates, or otherwise become violative—whichever comes first.

Withdrawal without prejudice to refiling

The FDA's withdrawal of approval is 'without prejudice' to refiling, meaning GlaxoSmithKline may apply in the future to seek approval again for Wellcovorin (NDA 018342).

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
4/10/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register